泰尼特 THC 深 沪
等待开盘 08-06 09:30:00 美东时间
161.55
+0.480
+0.30%
华盛通- 最 高162.375
- 今 开161.62
- 成交量 19.83万股
- 最 低 160.21
- 昨 收 161.07
- 总市值 150.06亿
- 52周最高 185.25
- 市盈率 静 4.94
- 换手率 0.21%
- 52周最低 109.8239
- 委 比 -45.97%
- 总股本 9288.50万
- 历史最高 185.25
- 量 比 0.34
- 振 幅 1.34%
- 历史最低 3.46
- 每 手 1
- 风险率 16.70%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多JP Morgan Maintains Overweight on Tenet Healthcare, Raises Price Target to $200
JP Morgan analyst Benjamin Rossi maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $190 to $200.
08-04 23:34
Tilray's Unique Strategy Could Make It A Winner As Cannabis, Beverages, And Wellness Mature
Investor interest in cannabis stocks has cooled since the legalization boom of ...
07-31 23:33
Wolfe Research Downgrades Tenet Healthcare to Peer Perform
Wolfe Research analyst Justin Lake downgrades Tenet Healthcare (NYSE:THC) from Outperform to Peer Perform.
07-28 18:42
What's Next: Universal Health Servs's Earnings Preview
Universal Health Servs (NYSE:UHS) is set to give its latest quarterly earnings ...
07-25 22:02
Centene, Cigna, Others Drop As Molina's Results Rattle Sector
Molina Healthcare missed Q2 EPS estimates and lowered its 2025 guidance, pressuring major health insurers including UnitedHealth and Centene.
07-25 02:12
美股大行评级 | 瑞银上调微软(MSFT)目标价升至600美元；花旗维持Unity 买入"评级，目标价从29美元升至44美元
今日重点评级关注：瑞银：维持泰尼特"买入"评级，目标价从230美元升至238美元；杰富瑞：维持BellRing Brands"买入"评级，目标价从80美元升至82美元
07-24 09:49
Guggenheim Maintains Buy on Tenet Healthcare, Raises Price Target to $188
Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $180 to $188.
07-23 20:53
Tenet Healthcare raises full year guidance, beats Q2 estimates
Tenet Healthcare (NYSE:THC) saw its shares increase on Tuesday following an upward revision of its revenue and profit forecasts for 2025, alongside better-than-expected Q2 results. The hospital operat...
07-22 21:45
Tenet Healthcare Board Authorizes $1.5B Increase To Stock Buyback
The Company's Board of Directors authorized a $1.5 billion increase to the share repurchase program. With this new authorization, the Company has $1.781 billion remaining under its repurchase authorization as of July 22,
07-22 18:55
Tenet Healthcare Raises FY2025 GAAP EPS Guidance from $11.37-$12.92 to $14.05-$15.15 vs $12.45 Est
Tenet Healthcare (NYSE:THC) raises FY2025 GAAP EPS guidance from $11.37-$12.92 to $14.05-$15.15 vs $12.45 analyst estimate..
07-22 18:47
